| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 433.27B | 403.26B | 403.69B | 408.46B | 409.51B | 449.12B |
| Gross Profit | 106.00B | 102.21B | 105.12B | 103.80B | 98.43B | 112.15B |
| EBITDA | 12.58B | 11.79B | 13.68B | 13.36B | 15.25B | 21.88B |
| Net Income | 3.81B | 3.41B | 4.89B | 4.97B | 6.39B | 8.87B |
Balance Sheet | ||||||
| Total Assets | 246.88B | 236.29B | 238.15B | 227.84B | 222.33B | 210.32B |
| Cash, Cash Equivalents and Short-Term Investments | 5.35B | 7.71B | 3.89B | 2.77B | 2.36B | 8.77B |
| Total Debt | 42.88B | 47.68B | 54.07B | 47.31B | 42.05B | 37.86B |
| Total Liabilities | 143.22B | 131.63B | 133.54B | 127.14B | 123.68B | 111.01B |
| Stockholders Equity | 103.66B | 104.67B | 104.61B | 100.70B | 98.64B | 99.30B |
Cash Flow | ||||||
| Free Cash Flow | 13.19B | 10.06B | -4.27B | -2.17B | -7.34B | 19.47B |
| Operating Cash Flow | 18.01B | 16.37B | 2.28B | 7.12B | 1.44B | 25.84B |
| Investing Cash Flow | -1.57B | -1.81B | -4.81B | -9.07B | -9.57B | -6.12B |
| Financing Cash Flow | -16.03B | -10.74B | 3.65B | 2.36B | 1.87B | -14.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥1.13T | 9.13 | 9.37% | 2.59% | -1.22% | -10.82% | |
71 Outperform | ¥576.74B | 14.44 | 9.06% | 1.84% | 0.42% | 20.25% | |
70 Outperform | ¥79.99B | 19.35 | ― | 5.60% | 5.91% | -21.23% | |
66 Neutral | ¥666.58B | 22.09 | 7.58% | 2.58% | 6.52% | -31.67% | |
66 Neutral | ¥310.75B | 2.68 | 4.97% | 2.01% | 2.00% | -68.35% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | ¥4.99T | 82.87 | 2.27% | 0.52% | 4.92% | 1.25% |